Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon, Matthew A. Lunning, Michael Wang, Jon Arnason, Amitkumar Mehta, Enkhtsetseg Purev, David G. Maloney, Charalambos Andreadis, Alison Sehgal, Scott R. Solomon, Nilanjan Ghosh, Tina M. Albertson, Jacob Garcia, Ana Kostic, Mary Mallaney, Ken Ogasawara, Kathryn Newhall, Yeonhee KimDaniel Li, Tanya Siddiqi

Research output: Contribution to journal › Article › peer-review

1202 Scopus citations

Fingerprint

Dive into the research topics of 'Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study'. Together they form a unique fingerprint.

Medicine & Life Sciences